MRNA:NASDAQ
Moderna Inc
$143.77
0.00%
(0.00) 1D
$144.48
arrow_upward
+0.49% (+0.71)todayPre-market
Closed: Sep 15, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MRNA...
Open
$146.00
High
$148.70
Low
$141.16
Mkt. cap
57.40B
Avg. vol.
24.98M
Volume
37.95K
52-wk high
$176.66
52-wk low
$22.29
EPS
-$7.98
Beta
1.10
Shares outstanding
399.24M
No. of employees
5K
Open
$146.00
High
$148.70
Low
$141.16
Mkt. cap
57.40B
Avg. vol.
24.98M
Volume
37.95K
52-wk high
$176.66
52-wk low
$22.29
EPS
-$7.98
Beta
1.10
Shares outstanding
399.24M
No. of employees
5K
News stories
From web sources and news partners
ad-hoc-news.de
·
6 hours ago
Moderna stock heads into the open after a near 2% Nasdaq loss
MarketBeat
·
13 hours ago
Moderna (NASDAQ:MRNA) Stock Price Down 2% Following Insider Selling
Zacks
·
18 hours ago
Is Cancer the Turnaround Moderna Has Been Looking for Post-COVID?
Stock Titan
·
20 hours ago
Another multimillion stock sale lined up for 2026 at Moderna (NASDAQ: MRNA)
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In 2026, Time ranked Moderna as number one in their World's Most Impactful Companies list. Wikipedia
About Moderna Inc